In the Know: Healthcare News for July 22, 2024
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
MEKanistic Therapeutics Inc.’s First-In-Class Dual EGFR and PI3K Investigational Therapy, MTX-531,Demonstrates Significant Tolerability and Durable Tumor Regressions in Preclinical Cancer Models
Neuspera Medical Raises $23 Million in Series D Financing